Bruno Sangro

Researcher Next ID · RN-002984

Researcher · Medicine

Pamplona, Spain

Not currently recruitingFunding unknown

Research interests

Medicine

Hepatocellular Carcinoma Treatment and Prognosis

Liver Disease Diagnosis and Treatment

Cancer Immunotherapy and Biomarkers

Cholangiocarcinoma and Gallbladder Cancer Studies

Liver Disease and Transplantation

Tremelimumab plus Durvalumab in Unresectable Hepatocellular Carcinoma
NEJM Evidence · 2022 · https://doi.org/10.1056/evidoa2100070
BCLC strategy for prognosis prediction and treatment recommendation: The 2022 update
Journal of Hepatology · 2021 · https://doi.org/10.1016/j.jhep.2021.11.018
Nivolumab in patients with advanced hepatocellular carcinoma (CheckMate 040): an open-label, non-comparative, phase 1/2 dose escalation and expansion trial
The Lancet · 2017 · https://doi.org/10.1016/s0140-6736(17)31046-2
Hepatocellular carcinoma
Nature Reviews Disease Primers · 2016 · https://doi.org/10.1038/nrdp.2016.18
Assessment of Liver Function in Patients With Hepatocellular Carcinoma: A New Evidence-Based Approach—The ALBI Grade
Journal of Clinical Oncology · 2014 · https://doi.org/10.1200/jco.2014.57.9151

No projects listed.